Patents
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
03/2001
03/15/2001WO2001017956A1 Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity
03/15/2001WO2001017955A2 Hydroxyacetamidobenzenesulphonamide derivatives
03/15/2001WO2001017942A1 Amides as inhibitors for pyruvate dehydrogenase
03/15/2001WO2000053583A8 Inhibitors of protein tyrosine phosphatase
03/15/2001WO2000051972A8 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful in therapy
03/15/2001US20010000038 Novel intermediates useful for the preparation of antihistaminic piperidine derivatives
03/15/2001DE19944066A1 New bis-alkynyl compounds having terminal nitrogen-containing functions or heterocycles, are tryptase inhibitors useful for treating inflammatory or allergic disease, especially respiratory disease, particularly asthma
03/15/2001DE19943636A1 Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften Novel dicarboxylic acid derivatives with pharmaceutical properties
03/15/2001DE19943635A1 Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften Novel Aminodicarbonsäurederivate with pharmaceutical properties
03/15/2001DE19942961A1 Verfahren zur Herstellung von aromatischen Aminen unter Katalyse von Palladaphosphacyclobutanen A process for the preparation of aromatic amines with catalysis by Palladaphosphacyclobutanen
03/15/2001DE19941559A1 Verwendung von Bissulfonamiden zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Hyperlipidömie Using Bissulfonamiden for the preparation of medicaments for the prophylaxis or treatment of Hyperlipidömie
03/15/2001CA2383782A1 Compounds for the treatment of viral infections
03/15/2001CA2381581A1 Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity
03/15/2001CA2318004A1 Novel polyamine analogues as therapeutic and diagnostic agents
03/14/2001EP1083163A2 Catalytic method for the preparation of aromatic amines using a palladaphosphacyclobutane compound as catalyst
03/14/2001EP1082314A1 New dipeptidyl peptidase iv effectors
03/14/2001EP1082308A1 Heterocyclically substituted amides used as calpain inhibitors
03/14/2001EP1082303A1 Heterocyclic derivatives which inhibit factor xa
03/14/2001EP1082297A1 Substituted dithio-bis-nitrobenzenes and their applications
03/14/2001EP1082295A1 Substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors
03/14/2001EP1082289A1 Methods for identifying novel multimeric agents that modulate receptors
03/14/2001EP1082121A1 Hiv integrase inhibitors
03/14/2001EP1082110A1 Use of compounds for the elevation of pyruvate dehydrogenase activity
03/14/2001EP0812205B1 Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
03/14/2001EP0682664B1 Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents
03/13/2001US6201133 Certain cyclic thio substituted acylaminoacid amide derivatives
03/13/2001US6201132 Inhibitors of membrane-bound serine protease; aminoacyl compounds
03/13/2001US6201130 N-arylsulfonylamino acid omega-amides
03/13/2001US6201122 Fluoroaliphatic radical-containing anionic sulfonamido compounds
03/13/2001US6201024 Effective p2x7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular disorders
03/13/2001US6201021 Pentanoic acid derivatives
03/13/2001US6201020 Effective poly(adenosine 5'-diphospho-ribose) polymerase (parp) inhibitor for treatment of tissue damage by necrosis or apoptosis; side effect reduction
03/13/2001CA2167651C Biologically highly active bicyclic aromatic compositions; pharmaceutical and cosmetic compositions containing the same and their use
03/08/2001WO2001016124A1 Cinnamic acid nitrile method of production and use thereof
03/08/2001WO2001016097A1 Phosphate mimics and methods of treatment using phosphatase inhibitors
03/08/2001WO2001016096A2 Use of bis-sulfonamides for producing medicaments used for preventing or treating hyperlipidaemia
03/08/2001WO2001016094A1 Sulfonyl carboxamide derivatives, method for their production and their use as medicaments
03/08/2001WO2000072800A3 Il-8 receptor antagonists
03/08/2001WO1999063930A8 Novel angiotensin receptor modulators and their uses
03/08/2001WO1999039704A8 Antibacterial agents
03/08/2001WO1999019296A8 Aminobutanoic acid derivatives
03/08/2001DE19941657A1 Zimtsäurenitrile, Verfahren zu ihrer Herstellung und Verwendung Cinnamonitriles, processes for their preparation and use
03/08/2001DE19941540A1 New 2,4-disubstituted 5-sulfonyl-benzamides or analogs having LDL receptor inducing activity, useful for treating or preventing hyperlipidemia or arteriosclerosis
03/08/2001CA2383783A1 Use of bis-sulfonamides for producing medicaments used for preventing or treating hyperlipidaemia
03/08/2001CA2383781A1 Sulfonyl carboxamide derivatives, method for their production and their use as medicaments
03/08/2001CA2382789A1 Phosphate mimics and methods of treatment using phosphatase inhibitors
03/07/2001EP1081142A2 Novel N-Aminoalkylfluorenecarboxamides; a new class of dopamine receptor subtype specific ligands
03/07/2001EP1080083A1 Novel heterocyclically substituted amides with cysteine protease-inhibiting effect
03/07/2001EP1080080A1 Novel therapeutic agents that modulate neurokinin receptors
03/07/2001EP1080066A1 Bioreductive cytotoxic agents
03/07/2001EP1079821A1 Protease inhibitors
03/07/2001EP1079819A1 Hydroxamic acid derivatives as antibacterials
03/07/2001EP1079763A2 Serotonergic 5ht 7? receptor compounds for treating ocular and cns disorders
03/07/2001CN1062862C Crystal complexes, its preparing method and composition contg same
03/07/2001CN1062859C Substd 1-naphthoyl guanidines, their preparing method, use and drug contg. them
03/06/2001US6197995 Process for manufacture of chiral succinic acid derivatives
03/06/2001US6197824 Benzamidine derivatives and the use thereof as medicaments with LTB4-antagonistic effect
03/06/2001US6197798 Inhibitors of microsomal triglyceride transfer protein
03/06/2001US6197791 N-hdroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
03/06/2001US6197789 Antidiabetic agents
03/06/2001US6197773 N-acyl and N-aroyl aralkyl amides as serotonergic agents
03/06/2001US6197770 Alkenyl- and alkynl-containing metalloprotease inhibitors
03/01/2001WO2001014355A1 Substituted piperazine derivatives, the production thereof and their utilization as medicaments
03/01/2001WO2001014331A2 Non-quinoline inhibitors of malaria parasites
03/01/2001WO2001014328A2 Substituted ureas as cell adhesion inhibitors
03/01/2001WO2001014320A1 Compounds that inhibit tryptase activity
03/01/2001WO2001014315A1 Aminohydroxylation of olefins
03/01/2001WO2001000617A3 Novel piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same, and a process for the preparation of the same
03/01/2001WO2000058270A3 Hsv primase inhibitors
03/01/2001DE19939910A1 Neue Verbindungen, die Tryptase-Aktivität hemmen Novel compounds that inhibit tryptase activity
03/01/2001CA2382311A1 Substituted piperazine derivatives, the preparation thereof and their use as medicaments
03/01/2001CA2381096A1 Compounds that inhibit tryptase activity
02/2001
02/28/2001EP1078917A1 Amidino derivatives and drugs containing the same as the active ingredient
02/28/2001EP1077976A1 Water soluble azoles as broad-spectrum antifungals
02/28/2001EP1077975A1 Water soluble azoles as broad-spectrum antifungals
02/28/2001EP1077962A2 Isocyanate derivatizing agent and methods of production and use
02/28/2001EP1077931A1 Benzamide derivatives for the treatment of diseases mediated by cytokines
02/28/2001EP1077930A1 Benzamide derivatives for the treatment of diseases mediated by cytokines
02/28/2001EP1077929A1 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia
02/28/2001EP1077928A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
02/28/2001EP1077927A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
02/28/2001EP1077925A1 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase
02/28/2001EP1077912A1 Novel derivatives of 3,3-diphenylpropylamines
02/28/2001EP0706796B1 Dopamine re-uptake inhibitors for the treatment of parkinson's syndrome
02/27/2001US6194577 Oxidizing 1-aminopyrrolidine in presence of inorganic base with air, oxygen or aqueous hydrogen peroxide as an oxidizing agent to form tetrahydropyridazine
02/27/2001US6194451 Prevent release tumor necrosis factor; antiinflammatory agents
02/27/2001US6194443 Aminophenol derivatives with fungicidal property
02/22/2001WO2001012584A2 Pharmaceutical compounds
02/22/2001WO2000071500A8 Halogen compounds
02/22/2001WO2000055126A3 N-cyanomethylamides as protease inhibitors
02/22/2001WO1999063996A8 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
02/22/2001DE19939745A1 New 1-carboxyalkyl-4-(hetero)aryl-piperazine derivatives as microsomal triglyceride transfer protein inhibitors, useful for reducing plasma atherogenic lipoprotein levels, e.g. in treatment of hyperlipidemia
02/22/2001DE19939516A1 New 1-carboxyalkyl-4-(hetero)aryl-piperazine derivatives, as microsomal triglyceride transfer protein inhibitors useful for reducing plasma atherogenic lipoprotein levels, e.g. in treatment of hyperlipidemia
02/22/2001CA2698353A1 Pharmaceutical compounds
02/22/2001CA2381409A1 Nitric ester derivatives
02/21/2001CN1062266C Amidine derivative and platelet agglutination inhibitor containing said amidine derivative
02/20/2001US6191277 Hydroxypropylamide peptidomimetics as inhibitors of aspartyl proteases
02/20/2001US6191182 Subjecting p-halophenyl alkyl ketone to aminolysis with cyclic secondary amine to form cyclic amine-substituted phenyl alkyl ketone; halogination and reacting with amine compound; stevens rearrangement under basic condition
02/20/2001US6191165 Pharmaceutical for treatment of neurological and neuropsychiatric disorders
02/20/2001US6191135 Respiratory system disorders, antiinflammatory agents; analgesics